High-ranking EU Commission officials give latest update on device directive recast text
This article was originally published in Clinica
The European Commission has already provided signposts as to the future content of the medical device directives recast in terms what aspects need updating and new subjects that will be addressed. Last week, at the Eucomed Medtech Forum in Brussels, those at the very heart of Europe’s forthcoming regulation decision-making on devices, European Commissioner John Dalli and director Jacqueline Minor, provided the very latest update to the 400-strong audience. Amanda Maxwell reports
You may also be interested in...
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.
2020 is not getting off to a good start for manufacturers needing to comply with the EU’s new Medical Device Regulation on 26 May 2020. The European Commission’s latest document seems to confirm industry’s fears about the ability of the EU’s medtech system to be ready in time.
December 2019 was a big month for far-reaching EU medtech regulatory developments that will have a significant impact on the way and speed of implementation of the Medical Device Regulation.